Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 6/20 | 0.58 |
| ▸ | AHR | P35869 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.46 |
| ▸ | GABRD | O14764 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.46 |
| ▸ | GABRE | P78334 | 1/20 | 0.46 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.46 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.46 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.46 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1276474 | 1.00 | KIF11 (0.58) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL12408493 | 1.00 | KIF11 (0.58) | KIF11AHRGABRPGABRDGABRA1 | |
| Phosphine SCHEMBL28966245 | 0.98 | KIF11 (0.57) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL17938403 | 0.92 | KIF11 (0.50) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL30196749 | 0.92 | KIF11 (0.50) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL8079075 | 0.80 | KIF11 (0.66) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL28217117 | 0.80 | KIF11 (0.66) | KIF11AHRALDH1A1HSD17B10GPR3 | |
| SCHEMBL8069561 | 0.78 | KIF11 (0.64) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL7108571 | 0.78 | KIF11 (0.64) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL7108566 | 0.78 | KIF11 (0.64) | KIF11AHRGABRPGABRDGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4594758-A2 | REACTIVE PROBES, PULL-DOWN, AND PURIFICATION METHODS FOR TAGGING BIOMOLECULES | Syncell (Taiwan) Inc. (TW) | 2025-08-06 | — | — | EP | claimed |
| WO-2024263832-A2 | CLICK DISPLAY COMPOSITIONS AND METHODS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2024-12-26 | — | — | WO | claimed |
| WO-2024102736-A1 | IMMOBILIZATION METHODS AND COMPOSITIONS FOR IN SITU DETECTION | 10X GENOMICS, INC. (US) | 2024-05-16 | — | — | WO | claimed |
| WO-2024092194-A2 | REACTIVE PROBES, PULL-DOWN, AND PURIFICATION METHODS FOR TAGGING BIOMOLECULES | Syncell (Taiwan) Inc. (TW) | 2024-05-02 | — | — | WO | claimed |
| WO-2024006799-A1 | COVALENT ATTACHMENT OF SPLINT OLIGONUCLEOTIDES FOR MOLECULAR ARRAY GENERATION USING LIGATION | 10X GENOMICS, INC. (US) | 2024-01-04 | — | — | WO | claimed |
| WO-2023122553-A1 | PHOTOLABILE SPATIAL LABEL GENERATION | ULTIMA GENOMICS, INC. (US) | 2023-06-29 | — | — | WO | claimed |
| EP-3450554-B1 | HIGH-SPEED IN VITRO SCREENING METHOD | EPSILON MOLECULAR ENG INC (JP) | 2022-09-21 | — | — | EP | claimed |
| EP-4735638-A2 | NUCLEIC ACID MOLECULE SEQUENCING SYSTEMS AND METHODS | Ultima Genomics, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026042741-A1 | CONJUGATE COMPRISING PROTEIN AND NUCLEIC ACID MOIETY, AND IMMUNODETECTION METHOD USING SAID CONJUGATE | 株式会社Epsilon Molecular Engineering | 2026-02-26 | — | — | WO | disclosed |
| US-12545700-B2 | Excitonic quantum computing via aggregate-aggregate coupling | BOISE STATE UNIVERSITY (US) | 2026-02-10 | — | — | US | disclosed |
| EP-4677111-A2 | SYSTEMS, METHODS, AND COMPOSITIONS FOR SEQUENCING | Ultima Genomics, Inc. (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-4655400-A1 | SYSTEMS AND METHODS FOR NUCLEIC ACID MISMATCH ERROR DETECTION | Ultima Genomics, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| WO-2025136916-A1 | THICK TISSUE TRANSCRIPTOMICS AND TRANSLATOMICS | THE BOARD INSTITUTE, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| WO-2024020395-A2 | BARCODE DIFFUSION-BASED SPATIAL OMICS | DIGITAL BIOLOGY INC. (US) | 2024-01-25 | — | — | WO | disclosed |
| WO-2024006799-A1 | COVALENT ATTACHMENT OF SPLINT OLIGONUCLEOTIDES FOR MOLECULAR ARRAY GENERATION USING LIGATION | 10X GENOMICS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| WO-2023188623-A1 | LINKER AND KIT | 株式会社トクヤマ | 2023-10-05 | — | — | WO | disclosed |
| WO-2023183881-A2 | TISSUE SPATIAL OMICS | DIGITAL BIOLOGY INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| US-20230147320-A1 | EXCITONIC QUANTUM COMPUTING VIA AGGREGATE-AGGREGATE COUPLING | BOISE STATE UNIVERSITY | 2023-05-11 | — | — | US | disclosed |
| WO-2023044489-A1 | PHOTOREACTIVE AND CLEAVABLE PROBES FOR TAGGING BIOMOLECULES | SYNCELL ( TAIWAN) INC. (TW) | 2023-03-23 | — | — | WO | disclosed |
| WO-2023278704-A1 | COMPOSITIONS AND METHODS FOR ENRICHMENT OF NUCLEIC ACIDS USING LIGHT-MEDIATED CROSS-LINKING | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545700-B2 | Excitonic quantum computing via aggregate-aggregate coupling | ELAVL1, ELAVL3, NCAPH | KIF11 2590/4885AHR 2421/4885GABRP 2182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.